c-peptide and Puerperal-Disorders

c-peptide has been researched along with Puerperal-Disorders* in 1 studies

Other Studies

1 other study(ies) available for c-peptide and Puerperal-Disorders

ArticleYear
Fulminant Type 1 Diabetes Mellitus Presenting 15 Days after Delivery Diagnosed in Cooperation with Obstetricians.
    Internal medicine (Tokyo, Japan), 2018, Oct-01, Volume: 57, Issue:19

    The patient was a 32-year-old Japanese woman who was given a 75-g oral glucose tolerance test at the 35th week of pregnancy and was normoglycemic. She had excessive thirst and polyuria from 15 days after delivery. When she visited for the 1-month postpartum checkup, her plasma glucose level was 479 mg/dL, HbA1c was 7.4%, and urinary C-peptide was 1.1 μg/mL; she was therefore diagnosed with fulminant type 1 diabetes mellitus associated with pregnancy. All physicians should be aware of this disease so as to provide a prompt diagnosis and emergency treatment and consequently improve the maternal prognosis.

    Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Humans; Puerperal Disorders

2018